BN Business News
Add your company to Business Communicator →

Business · 19/11/20261 min read

Evotec and Bristol Myers Squibb Advance Strategic Protein Degradation Partnership with Second IND Acceptance

EDITORIAL ILLUSTRATIONBBusinessBN
Illustration generated by Business News; it is not a source photograph.

Summary

FDA clearance expands partnered molecular glue pipeline Achievement underscores productivity of the collaboration in molecular glue discovery and potential to address patient populations with high unmet need HAMBURG, Germany, Nov. 19, 2026 — Evotec SE (NASDAQ: EVO)...

Original source language: PR Newswire — Global News ReleasesOpen original release →

Explore insights

Business insights →